A Case Control Observational Study to Assess CYDAR Automated Overlay Guidance During EVAR

Aortic Aneurysm Clinical Trial

— CYDAR-IRAAA  

Official title:

A Case Control Observational Study to Assess CYDAR Automated Overlay Guidance During EVAR

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02592733
• Other study ID #: IRAS171317
• Status: Completed
• First received: October 23, 2015
• Last updated: April 9, 2018
• Start date: November 2015
• Est. completion date: April 2018

Study information

• Verified date: April 2018
• Source: Royal Free Hospital NHS Foundation Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is an observational trial to determine if use of fusion imaging in infrarenal endovascular aneurysm repair will decrease the radiation dose and improve patient safety for this procedure.

Description:

The aorta is the main artery of the body. An aortic abdominal aneurysm (AAA) is defined as an abnormal dilatation of the aorta, based on a diameter of 3 cm or more, due to a weakness of the aortic wall that is prone to rupture, leading to a lifethreatening condition.

Once AAA diagnosed, a CTscan is required to assess the anatomy and if indicate an endovascular aneurysm repair (EVAR) is performed. This mini invasive procedure allows the exclusion of the AAA by positioning an endograft inside the aorta through a femoral access under live Xrays (fluoroscopy) guidance.

The Xrays are good at showing bones and radioopaque endovascular tools, but they do not show soft tissues like the aorta, and they produce flat (2D) images that superimpose all the 3D anatomical features. In order to see the aorta, physicians have to inject iodinated contrast during high quality imaging recording. One way to improve clinicians' perception of peroperative 3D vascular anatomy is to accurately overlay selected information from the preoperative CT scan (a 3D vascular mask) onto the live Xray image creating a '3D roadmap'. This advanced imaging application is currently available only in the latest expensive hybrid rooms. This trial will examine the clinical benefits of the first advanced imaging application allowing automated 3D overlay guidance during EVAR in any theatre. The software, combined with secure and certified cloud high performance computing, deduces the patient position from comparing the bony anatomy visible on the Xray to that on the patient's CT scan, enabling it to produce and update accurate and reliable overlays of the diagnostic CT 3D vascular mask throughout the operation (www.cydar.co.uk). Expected benefits include reducing the total Xray exposure of the patients and staff, reduced use of iodinated contrast (a major cause of kidney failure) and shortening procedure duration.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 44
• Est. completion date: April 2018
• Est. primary completion date: March 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. willing and able to give informed consent,and

2. aged 18 or older, and

3. been scheduled for endovascular repair of an infrarenal aortic aneurysm (EVAR), and

4. who have had a preoperative diagnostic CT scan, and

5. able (in the investigator's opinion) and willing to comply with the study requirements.

Exclusion Criteria:

1. Female participants who is pregnant or planning pregnancy during the course of the study.

2. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.

3. Any patient requiring an associated procedure (iliac branch device implantation, renal or mesenteric angioplasty)

4. Ruptured AAA and emergency procedures

Related Conditions & MeSH terms

• Aneurysm
• Aortic Aneurysm

Intervention

Device:
• CYDAR
CYDAR is an automated image mask that is cloud based adn delivered to operating theatres over a secure network. It fuses preoperative images with intraoperative images to provide more accurate image guidance for the surgeon.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Royal Free Hospital NHS Foundation Trust

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Radiation Dose (DAP)	The Dose Area Product acquired in surgery	This will be measured during the index operation. There will be no further radiation after that. Investigators expect that this study should take 12 months for full enrollment and analysis